Medical News

Comparison of 5 Beta-Blockers in Heart Failure with Reduced Ejection Fraction

24. 4. 2024 Source: Cardiovascular Continuum

An analysis of 26 studies with beta-blockers in the treatment of heart failure with reduced ejection fraction compared 5 drugs (bisoprolol, metoprolol-succinate, metoprolol-tartrate, carvedilol, and nebivolol). The results showed a more favorable prognosis with bisoprolol compared to carvedilol, a similar effect on prognosis for carvedilol, metoprolol-succinate, and nebivolol, and the least favorable prognosis with metoprolol-tartrate.

Long-term Benefit of Luspatercept Therapy –⁠ Fresh Data from the MEDALIST Study

The goal of therapy for low-risk myelodysplastic syndrome (MDS) is to compensate for anemia, improve or maintain quality of life, and prolong the time to progression to higher-risk MDS (HR-MDS) or…

22. 4. 2024 Source: Myelodysplastic Syndrome (MDS)

Use of Medical Cannabis in Patients with Fibromyalgia to Relieve Pain and Depression

Medical cannabis is prescribed to patients with chronic pain resistant to conventional treatments. The efficacy of tetrahydrocannabinol (THC) therapy in patients with fibromyalgia syndrome (FMS) was…

22. 4. 2024 Source: Medical Cannabis

Pilot Program for Lung Cancer Screening in the Czech Republic –⁠ Current Interim Results

Since January 1, 2022, a pilot population program for lung cancer screening has been underway in the Czech Republic. At the 7th PREVON conference in December 2023, updates on the progress as of March…

22. 4. 2024 Source: Small Cell Lung Cancer

Under the Microscope: How is Patient Care for Heart Failure in the Czech Republic in Real Practice?

The journal Vnitřní lékařství recently published the results of a survey conducted among outpatient cardiologists and internists. The aim was to determine the level of diagnosis and treatment of…

18. 4. 2024 Source: Heart Failure

Artificial Intelligence Helps in Selecting Influenza Strains for Vaccine Production

Vaccination is one of the most important and effective preventive measures in the fight against seasonal epidemics caused by influenza viruses each year. For vaccines to work, they must match the…

17. 4. 2024 Source:

Central European Expert Consensus on the Treatment of ITP in Adult Patients

In a recently published consensus, experts from Central Europe evaluate the current treatment options for immune thrombocytopenia (ITP) in adult patients and issue 7 recommendations for the…

15. 4. 2024 Source: Immune Thrombocytopenia

How do patients perceive the treatment of ITP with romiplostim?

Romiplostim, along with eltrombopag and avatrombopag, belongs to the group of thrombopoietin receptor agonists (TPO-RA) used in the second line of treatment for immune thrombocytopenia (ITP). Its…

15. 4. 2024 Source: Immune Thrombocytopenia

FDA Warns Against Self-Monitoring Glucose Using Smartwatches. What About in Czechia?

On February 21st, the U.S. Food and Drug Administration (FDA) issued a warning aimed at diabetic patients who measure their blood glucose levels (or are considering doing so) using smartwatches or…

12. 4. 2024 Source:

Where radical surgery cannot be performed in the subhepatic region or liver, there is room for radiation treatment

Proton radiotherapy continues to expand its indications in the treatment of oncological diseases. In the following interview, we focus on its role in treating tumors in the subhepatic region. MUDr.…

10. 4. 2024 Source: Proton Radiotherapy

You wouldn't believe what our AI can already do! "Snapshots" from research –⁠ 2024/8

Will we soon be living among robots? Artificial Intelligence (AI) has learned to design antibodies, diagnose tuberculosis from coughing sounds, and in its spare time, improve beer. If that scares you…

10. 4. 2024 Source: proLékaře.cz

Scientists Create First Functional Brain Tissue Using 3D Printing

A research team from the University of Wisconsin-Madison has successfully printed the first ever functional brain tissue using a commercial 3D printer in their laboratory. This breakthrough may be…

9. 4. 2024 Source:

Prof. Miloš Broďák: Introduction of new drugs has significantly improved results even in progressive and recurrent prostate cancers

The prognosis and treatment outcomes for patients with various stages of prostate cancer have significantly improved over the past two decades thanks to a number of new or improved modalities of…

3. 4. 2024 Source: Oncological Treatment

Subcutaneous zilucoplan –⁠ the end of necessary “trips” to the hospital for myasthenia gravis patients?

A study recently published in Lancet Neurology demonstrated the efficacy and safety of the subcutaneously administered complement component C5 inhibitor –⁠ zilucoplan –⁠ in the treatment of myasthenia…

3. 4. 2024 Source: Rare Diseases in Neurology

Wireless Smart Devices Monitor Health by Detecting Sounds

The human body continuously emits various forms of acoustic-mechanical signals that can provide important information about its health. Researchers from Northwestern University in the USA have…

2. 4. 2024 Source:

1 … 12 13 14 15 16 … 111

Back Filter by speciality

Remove filters

Popular this week